Skip to content

AbbVie ABBV Current Debt

Current Debt at other companies

Eli Lilly logo
Eli LillyLLY
$4B-0.4%
Pfizer logo
PfizerPFE
$3.86B+3.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$11.69B+1.4%
Amgen logo
AmgenAMGN
$5.44B+61.4%
Incyte logo
IncyteINCY
$4.26M-4.8%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$889M+215%

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$465.02B+37.7%
P/E127.9×+38.2×
P/S7.4×+1.6×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:ShortTermBorrowings.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's current debt?
AbbVie (ABBV) reported current debt of $0 in Q1 2026.
How has AbbVie's current debt changed year-over-year?
AbbVie's current debt decreased by 100.0% year-over-year, from $1.59B to $0.
What is the long-term trend for AbbVie's current debt?
Over 5 years (2020 to 2025), AbbVie's current debt has grown at a 136.2% compound annual growth rate (CAGR), from $34M to $2.5B.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.